Correlation Between Editas Medicine and Dicerna Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Editas Medicine and Dicerna Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Editas Medicine and Dicerna Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Editas Medicine and Dicerna Pharmaceuticals, you can compare the effects of market volatilities on Editas Medicine and Dicerna Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Editas Medicine with a short position of Dicerna Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Editas Medicine and Dicerna Pharmaceuticals.

Diversification Opportunities for Editas Medicine and Dicerna Pharmaceuticals

0.0

Correlation Coefficient

Editas Medicine  Dicerna Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Editas and Dicerna is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Editas Medicine and Dicerna Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dicerna Pharmaceuticals and Editas Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Editas Medicine are associated (or correlated) with Dicerna Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dicerna Pharmaceuticals has no effect on the direction of Editas Medicine i.e., Editas Medicine and Dicerna Pharmaceuticals go up and down completely randomly.

Pair Corralation between Editas Medicine and Dicerna Pharmaceuticals

If you would invest (100.00) in Dicerna Pharmaceuticals on January 20, 2024 and sell it today you would earn a total of  100.00  from holding Dicerna Pharmaceuticals or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Editas Medicine  vs.  Dicerna Pharmaceuticals

Editas Medicine

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Editas Medicine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in May 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Dicerna Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dicerna Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Dicerna Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Editas Medicine and Dicerna Pharmaceuticals

The main advantage of trading using opposite Editas Medicine and Dicerna Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Editas Medicine position performs unexpectedly, Dicerna Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dicerna Pharmaceuticals will offset losses from the drop in Dicerna Pharmaceuticals' long position.

The idea behind Editas Medicine and Dicerna Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.